Inomata M, Konno S, Azuma A. Historical transition of management of sarcoidosis. World J Respirol 2015; 5(1): 4-16 [DOI: 10.5320/wjr.v5.i1.4]
Corresponding Author of This Article
Arata Azuma, MD, PhD, Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan. a-azuma@nms.ac.jp
Research Domain of This Article
Respiratory System
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Respirol. Mar 28, 2015; 5(1): 4-16 Published online Mar 28, 2015. doi: 10.5320/wjr.v5.i1.4
Historical transition of management of sarcoidosis
Minoru Inomata, Satoshi Konno, Arata Azuma
Minoru Inomata, Arata Azuma, Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Bunkyo-ku, Tokyo 113-8603, Japan
Satoshi Konno, First Department of Medicine, Hokkaido University School of Medicine, Kita-ku, Sapporo 060-8638, Japan
Author contributions: Inomata M and Konno S equally contributed to this paper; Azuma A revised the manuscript critically for important intellectual content.
Supported by Arata Azuma has received grants from Ministry of Health, Welfare and Labor of Japan.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Arata Azuma, MD, PhD, Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan. a-azuma@nms.ac.jp
Telephone: +81-3-38222131 Fax: +81-3-56853075
Received: October 23, 2014 Peer-review started: October 24, 2014 First decision: January 8, 2015 Revised: January 24, 2015 Accepted: February 9, 2015 Article in press: February 10, 2015 Published online: March 28, 2015
Core Tip
Core tip: Sarcoidosis, a systemic granulomatous disease of undetermined etiology, is characterized by a variable clinical presentation and course. Propionibacterium acnes (P. acnes)-specific monoclonal antibodies can detect P. acnes, a causative microorganism, and are useful for diagnosing sarcoidosis. The importance of 18F-fluorodeoxyglucose positron-emission tomography and endobronchial ultrasonography-guided transbronchial needle aspiration to diagnose sarcoidosis is progressively increasing. Cardiac sarcoidosis is the main cause of death in Japan. The 2006 Japanese guidelines for diagnosing cardiac sarcoidosis are useful, particularly for subclinical cardiac sarcoidosis patients. Further studies and international communication and evaluation are needed to improve our management of sarcoidosis.
